evidence_canine_feline_hyperlipidemia_diet
Source: first-hand peer-reviewed abstracts (Europe PMC / PubMed efetch), reproduced verbatim. Each claim below is a C1 substring of the cited source file.
Claims (C1 — verbatim substrings of source_file)
- PMID 42201424 — Pilot study of the use of ezetimibe in dogs with hyperlipidemia (Veterinary research communications, 2026). Abstract (opening): The aim of this study was to evaluate the tolerance and efficacy of ezetimibe in reducing cholesterol and/or triglycerides in dogs with hyperlipidemia. Twenty-three dogs with hyperlipidemia were randomly distributed into three groups: group D (n = 7) received low-fat dietary treatment, group E (n = 9) received ezetimibe treatment, and group DE (n = 7) received low-fat dietary treatment associated with ezetimibe.
Source: pdf-raw/evidence/europepmc_hyperlipidemia_2026-07-30.txt